首页> 美国卫生研究院文献>The Journal of Veterinary Medical Science >New clinical application of three-dimensional-printed polycaprolactone/β-tricalcium phosphate scaffold as an alternative to allograft bone for limb-sparing surgery in a dog withdistal radial osteosarcoma
【2h】

New clinical application of three-dimensional-printed polycaprolactone/β-tricalcium phosphate scaffold as an alternative to allograft bone for limb-sparing surgery in a dog withdistal radial osteosarcoma

机译:三维打印的聚己内酯/β-磷酸三钙磷酸钙支架替代同种异体骨在犬肢体保留手术中的新临床应用远端radial骨肉瘤

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Limb-sparing surgery is one of the surgical options for dogs with distal radial osteosarcoma (OSA). This case report highlights the novel application of a three-dimensional (3D)-printed patient-specific polycaprolactone/β-tricalcium phosphate (PCL/β-TCP) scaffold in limb-sparing surgery in a dog with distal radial OSA. The outcomes evaluated included postoperative gait analysis, complications, local recurrence of tumor, metastasis, and survival time. Post-operative gait evaluation showed significant improvement in limb function, including increased weight distribution and decreased asymmetry. The implant remained well in place and increased bone opacity was observed between the host bone and the scaffold. There was no complication due to scaffold or surgery. Significant improvement in limb function and quality of life was noted postoperatively. Local recurrence and pulmonary metastasis were identified at 8 weeks postoperatively. The survival time from diagnosis of OSA to death was 190 days. The PCL/β-TCP scaffold may be an effective alternative to cortical allograft in limb-sparing surgery for bone tumors.
机译:保留肢体手术是with骨远端骨肉瘤(OSA)犬的外科手术选择之一。该病例报告强调了三维(3D)打印的患者特异性聚己内酯/β-磷酸三钙(PCL /β-TCP)支架在具有远端radial骨OSA的狗的保肢手术中的新应用。评估的结果包括术后步态分析,并发症,肿瘤的局部复发,转移和生存时间。术后步态评估显示肢体功能明显改善,包括体重分布增加和不对称性降低。植入物保持在适当位置,并且在宿主骨和支架之间观察到骨不透明性增加。没有因支架或手术引起的并发症。术后肢体功能和生活质量显着改善。术后8周发现局部复发和肺转移。从诊断OSA到死亡的生存时间为190天。在骨骼肿瘤的保肢手术中,PCL /β-TCP支架可能是皮质同种异体移植的有效替代方法。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号